{"paper_count": 228, "drug_molecule_count": 8, "paper_count_year": {"1988": [1, 1, 2], "1989": [1, 0, 2], "1991": [1, 1, 0], "1993": [1, 0, 6], "1997": [1, 4, 2], "1998": [1, 5, 2], "2005": [1, 0, 13], "2006": [2, 8, 5], "2007": [3, 6, 4], "2008": [1, 6, 15], "2009": [3, 15, 32], "2010": [6, 20, 34], "2011": [6, 17, 43], "2012": [11, 18, 45], "2013": [9, 16, 59], "2014": [11, 13, 57], "2015": [15, 17, 42], "2016": [15, 22, 43], "2017": [13, 15, 56], "2018": [23, 20, 39], "2019": [34, 23, 31], "2020": [35, 24, 45], "2021": [34, 39, 37], "1911": [0, 1, 0], "1935": [0, 1, 0], "1940": [0, 1, 0], "1946": [0, 1, 0], "1949": [0, 2, 0], "1966": [0, 1, 0], "1971": [0, 1, 0], "1972": [0, 2, 1], "1976": [0, 1, 0], "1981": [0, 2, 1], "1982": [0, 1, 2], "1983": [0, 1, 3], "1987": [0, 4, 3], "1990": [0, 3, 3], "1992": [0, 2, 3], "1994": [0, 1, 7], "1995": [0, 3, 3], "1996": [0, 2, 0], "1999": [0, 4, 4], "2000": [0, 1, 4], "2001": [0, 2, 1], "2002": [0, 3, 6], "2003": [0, 9, 1], "2004": [0, 3, 7], "1832": [0, 0, 1], "1837": [0, 0, 1], "1894": [0, 0, 1], "1902": [0, 0, 1], "1903": [0, 0, 1], "1904": [0, 0, 2], "1909": [0, 0, 1], "1912": [0, 0, 1], "1914": [0, 0, 1], "1921": [0, 0, 3], "1922": [0, 0, 1], "1932": [0, 0, 1], "1939": [0, 0, 1], "1943": [0, 0, 3], "1945": [0, 0, 1], "1947": [0, 0, 1], "1948": [0, 0, 1], "1951": [0, 0, 2], "1958": [0, 0, 1], "1960": [0, 0, 1], "1961": [0, 0, 1], "1967": [0, 0, 3], "1968": [0, 0, 1], "1969": [0, 0, 2], "1970": [0, 0, 2], "1973": [0, 0, 2], "1977": [0, 0, 1], "1978": [0, 0, 1], "1979": [0, 0, 2], "1980": [0, 0, 2], "1984": [0, 0, 2], "1985": [0, 0, 2], "1986": [0, 0, 2]}, "drug_molecule_paper": [{"paper_id": 0, "paper_title": "Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors", "paper_author": ["Pingyuan Wang", "Dharini van der Hoeven", "Na Ye", "Haiying Chen", "Zhiqing Liu", "Xiaoping Ma", "Dina Montufar-Solis", "Kristen M. Rehl", "Kwang-Jin Cho", "Sabita Thapa", "Wei Chen", "Ransome van der Hoeven", "Jeffrey A. Frost", "John F. Hancock", "Jia Zhou"], "paper_year": 2021, "paper_institution": "Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, USA", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113381", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002300-ga1_lrg.jpg", "compound_count": 29, "compound_name": "22", "compound_name_drug": "", "compound_smiles": "C1N(CCC1)CCN([C@@H](c1ccc(OC)cc1)C)CC=C(c1ccccc1)c1ccccc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 20.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"paper_id": 1, "paper_title": " inhibitors", "paper_author": ["Xuanzheng Xiao", "Mengzhen Lai", "Zilan Song", "Meiyu Geng", "Jian Ding", "Hua Xie", "Ao Zhang"], "paper_year": 2021, "paper_institution": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China", "paper_cited": 0, "doi": "10.1016/j.ejmech.2020.113082", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420310540-fx1_lrg.jpg", "compound_count": 19, "compound_name": "26a", "compound_name_drug": "", "compound_smiles": "c1(ccnc2c1n1c3c(c(c4c(F)cccc4O)ncc3c(nc1=[O]C2C)N1[C@H](CN(CC1)C(=O)C=C)C)F)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"paper_id": 2, "paper_title": "Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors", "paper_author": ["Seok Jong Kang", "Jung Wuk Lee", "Shin Hyuck Chung", "Sun Young Jang", "Jaeyul Choi", "Kwee Hyun Suh", "Young Hoon Kim", "Young Jin Ham", "Kyung Hoon Min"], "paper_year": 2019, "paper_institution": "College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea", "paper_cited": 2, "doi": "10.1016/j.ejmech.2018.12.025", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418310626-fx1_lrg.jpg", "compound_count": 21, "compound_name": "22a", "compound_name_drug": "", "compound_smiles": "N(C1CC1)c1c2nccn2c(cn1)c1c(C)cc(NC(=O)Nc2n(nc(C(C)(C)C)c2)c2ccccc2)cc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 3144.0, "solubility": 0.0, "t_half": 1.6, "bioavailability": 25.0}, "clinical_statistics": {}}, {"paper_id": 3, "paper_title": "Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer", "paper_author": ["Huan Tang", "Yongguang Zhang", "Dan Li", "Suhong Fu", "Minghai Tang", "Li Wan", "Kai Chen", "Zhuowei Liu", "Linlin Xue", "Aihua Peng", "Haoyu Ye", "Lijuan Chen"], "paper_year": 2018, "paper_institution": "State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China", "paper_cited": 14, "doi": "10.1016/j.ejmech.2018.06.048", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418305397-fx1_lrg.jpg", "compound_count": 18, "compound_name": "00", "compound_name_drug": "", "compound_smiles": "C(C=C)c1cc(CN2CCC(N)CC2)c(O)c(c2cc(CC=C)ccc2O)c1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"paper_id": 4, "paper_title": "\n            ", "paper_author": ["Yi-Min Liu", "Huang-Ju Tu", "Chueh-Heng Wu", "Mei-Jung Lai", "Shu-Chieh Yu", "Min-Wu Chao", "Yi-Wen Wu", "Che-Ming Teng", "Shiow-Lin Pan", "Jing-Ping Liou"], "paper_year": 2021, "paper_institution": "School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113428", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002774-ga1_lrg.jpg", "compound_count": 11, "compound_name": "3a", "compound_name_drug": "", "compound_smiles": "c1(cnccc1)N(C(=O)c1c(cc(O)c(C(C)C)c1)O)CC", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 17.8}, "clinical_statistics": {}}, {"paper_id": 5, "paper_title": "Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)", "paper_author": ["Hao Zhang", "Hong-Yi Zhao", "Xiao-Xiao Xi", "Yan-Jie Liu", "Minhang Xin", "Shuai Mao", "Jun-Jie Zhang", "A-Xin Lu", "San-Qi Zhang"], "paper_year": 2020, "paper_institution": "Department of Medicinal Chemistry, School of Pharmacy, Xi′an Jiaotong University, Xi′an, Shaanxi, 710061, PR China", "paper_cited": 21, "doi": "10.1016/j.ejmech.2020.112061", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420300283-fx1_lrg.jpg", "compound_count": 14, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "C(C1CCN(CC1)c1nc(nc2c1cc(nc2)Nc1ncc(N2CCN(CC2)CCCCCCCC(=O)Nc2c3c(C(=O)N(C4C(=O)NC(=O)CC4)C3)ccc2)cc1)Nc1ccc(F)cc1)O", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"paper_id": 6, "paper_title": "Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer", "paper_author": ["Gang Liu", "Tao Yin", "Hyejin Kim", "Chunyong Ding", "Zhuo Yu", "Hong Wang", "Haiying Chen", "Ruping Yan", "Eric A. Wold", "Hao Zou", "Xi Liu", "Ye Ding", "Qiang Shen", "Jia Zhou"], "paper_year": 2019, "paper_institution": "Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, United States", "paper_cited": 3, "doi": "10.1016/j.ejmech.2019.06.004", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419305215-fx1_lrg.jpg", "compound_count": 2, "compound_name": "49", "compound_name_drug": "", "compound_smiles": "c1ccc2c(c1)/C(=C\\c1cccnc1OCCN)/c1c2ccc(N(=O)=O)c1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"paper_id": 7, "paper_title": " promoter G-quadruplex binding ligands", "paper_author": ["Qian-Liang Guo", "Hua-Fei Su", "Ning Wang", "Sheng-Rong Liao", "Yu-Ting Lu", "Tian-Miao Ou", "Jia-Heng Tan", "Ding Li", "Zhi-Shu Huang"], "paper_year": 2017, "paper_institution": "School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, People's Republic of China", "paper_cited": 18, "doi": "10.1016/j.ejmech.2017.02.051", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417301241-fx1_lrg.jpg", "compound_count": 21, "compound_name": "2b", "compound_name_drug": "", "compound_smiles": "O(C)c1cc2CCc3c(NCCCN(CC)CC)c4ccccc4nc3c2cc1OC", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 9200.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}], "medicinal_chemistry_similarity": [{"source": 0, "target": 1, "value": 0.0}, {"source": 0, "target": 2, "value": 0.24884488448844885}, {"source": 0, "target": 3, "value": 0.3369447453954496}, {"source": 0, "target": 4, "value": 0.2988505747126437}, {"source": 0, "target": 5, "value": 0.2836835599505562}, {"source": 0, "target": 6, "value": 0.25249169435215946}, {"source": 0, "target": 7, "value": 0.27722772277227725}, {"source": 1, "target": 2, "value": 0.0}, {"source": 1, "target": 3, "value": 0.0}, {"source": 1, "target": 4, "value": 0.0}, {"source": 1, "target": 5, "value": 0.0}, {"source": 1, "target": 6, "value": 0.0}, {"source": 1, "target": 7, "value": 0.0}, {"source": 2, "target": 3, "value": 0.3049095607235142}, {"source": 2, "target": 4, "value": 0.36086404066073696}, {"source": 2, "target": 5, "value": 0.5627729257641921}, {"source": 2, "target": 6, "value": 0.42661691542288555}, {"source": 2, "target": 7, "value": 0.5337278106508876}, {"source": 3, "target": 4, "value": 0.37662337662337664}, {"source": 3, "target": 5, "value": 0.3323262839879154}, {"source": 3, "target": 6, "value": 0.2932806324110672}, {"source": 3, "target": 7, "value": 0.3505586592178771}, {"source": 4, "target": 5, "value": 0.4018072289156627}, {"source": 4, "target": 6, "value": 0.3158682634730539}, {"source": 4, "target": 7, "value": 0.3570957095709571}, {"source": 5, "target": 6, "value": 0.41334093500570124}, {"source": 5, "target": 7, "value": 0.5513966480446927}, {"source": 6, "target": 7, "value": 0.4153846153846154}]}